Cite
APA Citation
Garland, R., Kirkham, C., Yap, M., Brackenbury, L., Iannitti, T., Nunan, R., & Jenkinson, S. (n.d.). 6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery. Journal for immunotherapy of cancer, 8, A3–A4. http://access.bl.uk/ark:/81055/vdc_100144716975.0x000003